It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
Expertise in exosomes isolation and characterization will drive innovation in this field
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
This test can be run on commonly available qPCR cyclers, thereby, bypassing the need to perform expensive and time-consuming Next-Generation Sequencing
The aim is to create new genomics solutions that could combat cancer and advance market access
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Subscribe To Our Newsletter & Stay Updated
